What is on the differential diagnosis for Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)?

Key differentials include Cerebral venous sinus thrombosis, Intracranial mass / hydrocephalus, Meningitis (chronic) — cryptococcal, TB, neoplastic, Malignant hypertension, Optic neuritis, Migraine.

What are the high-yield PANCE pearls for Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)?

Vision loss — not headache — is the most dangerous feature. Visual fields drive urgency of intervention. Always perform MRV before lumbar puncture in suspected IIH to exclude cerebral venous sinus thrombosis. Empty sella, posterior globe flattening, and bilateral transverse sinus stenosis are imaging clues to longstanding raised ICP. Pulsatile tinnitus is a highly characteristic but underrecognized symptom. The NORDIC trial established acetazolamide + weight loss as first-line for mild-moderate IIH.

Neurology · PANCE / PANRE

Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

Written & clinically reviewed by Ryan Busch, PA-C · Updated July 2026 · Report an error

Elevated intracranial pressure without an identifiable mass or hydrocephalus; classically affects young, obese women with headache and papilledema.

Also known as: IIH, pseudotumor cerebri, benign intracranial hypertension, BIH

Overview

A syndrome of elevated intracranial pressure (CSF opening pressure >25 cm H2O in adults, >28 cm H2O in children) in the absence of structural, vascular, or infectious causes, with normal CSF composition and no ventriculomegaly. Diagnosed by modified Dandy criteria.

Epidemiology

Annual incidence ~1 per 100,000 overall, rising to ~20 per 100,000 in obese women of childbearing age. >90% of affected adults are women with BMI >30. Rising incidence parallels obesity prevalence.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → Sign in

Free to start · No credit card · Cancel anytime

Risk factors

Obesity, especially rapid weight gain
Female sex, reproductive age (15-45)
Medications: tetracyclines (doxycycline, minocycline), retinoids (isotretinoin, vitamin A excess), growth hormone, lithium, corticosteroid withdrawal, oral contraceptives (weak association)
Polycystic ovary syndrome
Obstructive sleep apnea
Anemia, particularly iron-deficiency

Pathophysiology

Mechanism incompletely understood. Leading hypotheses: impaired CSF outflow at arachnoid granulations, increased intracranial venous pressure from transverse sinus stenosis, and altered glymphatic drainage. Obesity and increased intra-abdominal pressure may raise central venous pressure and reduce CSF absorption.

Clinical presentation

Symptoms

Headache — daily, generalized, throbbing or pressure-like; often worse on awakening or with Valsalva
Transient visual obscurations — seconds-long graying or dimming of vision, often with postural change
Pulsatile tinnitus — whooshing in time with heartbeat
Diplopia from CN VI palsy (false localizing sign of elevated ICP)
Photopsia, blurred vision, progressive visual field loss
Back or radicular pain

Signs / physical exam

Bilateral optic disc edema (papilledema) — hallmark; grade by Frisén scale
Visual field deficits — enlarged blind spot, inferior nasal loss, peripheral constriction
Reduced visual acuity in advanced disease
Cranial nerve VI palsy (unilateral or bilateral)
Otherwise normal neurologic exam

Classic findings

Young obese woman with daily headache, transient visual obscurations, pulsatile tinnitus, and bilateral papilledema.

Differential diagnosis

Cerebral venous sinus thrombosis — Headache + papilledema + raised ICP, especially postpartum, OCP use, thrombophilia — exclude with MRV before diagnosing IIH
Intracranial mass / hydrocephalus — Focal deficit, asymmetric papilledema, ventriculomegaly on imaging
Meningitis (chronic) — cryptococcal, TB, neoplastic — CSF pleocytosis, abnormal protein/glucose, positive cultures or cytology
Malignant hypertension — Very high BP, exudates, hemorrhages, end-organ damage
Optic neuritis — Painful monocular vision loss, RAPD, central scotoma — unilateral and acute
Migraine — Episodic, no papilledema, no chronic visual loss, normal imaging

Diagnostic workup

Diagnostic criteria

Modified Dandy criteria: (1) signs/symptoms of raised ICP, (2) no localizing neurologic findings except CN VI palsy, (3) normal CSF composition, (4) CSF opening pressure elevated, (5) normal neuroimaging (no mass/hydrocephalus/vascular abnormality), (6) no other identified cause.

Labs

CBC, BMP, ESR/CRP, ANA (exclude inflammatory causes if atypical)
Thrombophilia workup if cerebral venous sinus thrombosis suspected

Imaging

MRI brain with venography (MRV) — exclude mass, hydrocephalus, and cerebral venous sinus thrombosis BEFORE lumbar puncture
Imaging findings suggestive of raised ICP: empty sella, posterior globe flattening, optic nerve sheath dilation/tortuosity, transverse sinus stenosis
Lumbar puncture in lateral decubitus position with manometry — CSF opening pressure >25 cm H2O (>28 in children); normal CSF composition
Formal visual fields (Humphrey 24-2) and dilated funduscopy with OCT of the optic nerve at diagnosis and serially

Diagnostic algorithm

flowchart TD
  A[Headache + papilledema<br/>± transient visual obscurations] --> B[MRI brain + MRV<br/>(exclude mass, hydrocephalus,<br/>venous thrombosis)]
  B --> C{Imaging normal?}
  C -->|No| D[Treat underlying cause]
  C -->|Yes| E[Lumbar puncture<br/>with manometry]
  E --> F{Opening pressure<br/>>25 cm H2O,<br/>normal CSF?}
  F -->|No| G[Reconsider diagnosis]
  F -->|Yes| H[IIH confirmed<br/>(Modified Dandy)]
  H --> I[Weight loss<br/>+ acetazolamide<br/>± topiramate]
  I --> J{Progressive<br/>vision loss?}
  J -->|Yes| K[Optic nerve sheath<br/>fenestration or<br/>CSF shunt or<br/>venous sinus stent]
  J -->|No| L[Serial fields,<br/>OCT, fundus exam]

Diagnostic and management algorithm for idiopathic intracranial hypertension.

Treatment

First-line

Weight loss — sustained loss of 6-10% of body weight reduces papilledema and headache
Acetazolamide 250-500 mg PO BID, titrated up to 4 g/day as tolerated — first-line carbonic anhydrase inhibitor; monitor for paresthesias, metabolic acidosis, hypokalemia, kidney stones
Topiramate — alternative or adjunct; helps headache and may aid weight loss
Discontinue offending medications (tetracyclines, retinoids, exogenous vitamin A)
Headache co-management with usual abortive and preventive strategies

Sight-threatening (fulminant) IIH

Emergent ophthalmology and neurosurgery consult
Optic nerve sheath fenestration — for progressive vision loss with manageable headache
CSF shunting (VP or LP shunt) — for severe headache + vision loss; higher revision rate
Venous sinus stenting — for documented stenosis with pressure gradient (selected centers)
Serial high-volume LPs as temporizing measure if surgical delay

Pregnancy

Acetazolamide may be used after the first trimester per ACOG/NORDIC pregnancy committee guidance
Close ophthalmologic monitoring; weight management deferred
Vaginal delivery generally safe; epidural anesthesia not contraindicated

Second-line / adjunct

Bariatric surgery for refractory disease with severe obesity (BMI ≥35-40)
GLP-1 receptor agonists (semaglutide, tirzepatide) — emerging adjunct for weight loss in IIH

Complications

Permanent vision loss — the most feared complication; affects up to 25% of severely affected patients
Optic atrophy with chronic papilledema
Chronic disabling headache
Medication intolerance (acetazolamide paresthesias, taste changes; topiramate cognitive effects)
Shunt failure or infection if surgically managed

PANCE pearls

Vision loss — not headache — is the most dangerous feature. Visual fields drive urgency of intervention.
Always perform MRV before lumbar puncture in suspected IIH to exclude cerebral venous sinus thrombosis.
Empty sella, posterior globe flattening, and bilateral transverse sinus stenosis are imaging clues to longstanding raised ICP.
Pulsatile tinnitus is a highly characteristic but underrecognized symptom.
The NORDIC trial established acetazolamide + weight loss as first-line for mild-moderate IIH.

References

NORDIC Trial — Wall M et al. Effect of acetazolamide on visual function in patients with IIH and mild visual loss. JAMA 2014;311:1641-1651.
Friedman 2013 — Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159-1165.
AAO/AAN guidance — Joint AAO/AAN guidance on management of papilledema in IIH (consensus statements).

Practice Neurology questions on FirstPassPA

Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.